Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Authors
Yusuke Yoshimura,
Masayuki YamanouchiHiroki Mizuno,
Daisuke Ikuma,
Ryo Koizumi,
Shigekazu Kurihara,
Yuki Oba,
Tatsuya Suwabe,
Yuichiro Sawada,
Kenichi Ohashi,
Hisashi Sugimoto,
Masato Mizuta,
Akinari Sekine,
Eiko Hasegawa,
Yoshifumi Ubara,
Naoki Sawa +14 authors
,
Saburo Kurihara 
TipTip 
